| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 14,105 | 14,584 | 13,619 | 13,503 | | Cost of Revenue | 5,408 | 5,228 | 5,268 | 5,110 | | | Gross Profit | 8,697 | 9,355 | 8,351 | 8,393 | | | Operating Expenses | | Research Development | 1,620 | 1,447 | 1,534 | 1,524 | | Selling General and Administrative | 4,692 | 4,796 | 4,615 | 4,554 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 1,305 | 1,250 | 1,266 | 1,193 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 1,079 | 1,862 | 936 | 1,123 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 4 | 7 | 9 | 22 | | Earnings Before Interest And Taxes | 1,083 | 1,869 | 945 | 1,144 | | Interest Expense | 13 | 9 | 10 | 13 | | Income Before Tax | 1,070 | 1,860 | 935 | 1,131 | | Income Tax Expense | 47 | 132 | 57 | (309) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 1,023 | 1,728 | 878 | 1,441 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,023 | 1,728 | 878 | 1,441 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,023 | $1,728 | $878 | $1,441 |
|
0.51% Nasdaq 
Income Statement
